Join our Solution Spotlight presentation - 25th May 11:00-11:15
Are you ready to embark on an exciting journey into the world of high-throughput cell engineering? Get ready to be amazed by the possibilities of this cutting-edge technology as we explore how it’s transforming the field of life science research. Say goodbye to labor-intensive, low-throughput workflows, and hello to automated, high-throughput cell engineering that’s revolutionizing biotherapeutic discovery, disease modeling, and synthetic biology research. Come join us for a friendly, informative, and engaging talk that will leave you inspired and eager to explore the limitless potential of high-throughput cell engineering in microfluidic picodroplets. Save the date now!
Presentation Title: High-throughput Cell Engineering in Microfluidic Picodroplets
Presentation Summary: Cell engineering is bringing life science into a new era of novel approaches for biotherapeutic discovery and development, disease modeling, and synthetic biology research. Many current technologies used in cell engineering workflows typically involve multistep operations, high hands-on time, and lengthy liquid handling processes as well as low throughput bioassays for functional validation and verification. We wished to investigate the use of experimental tools to potentially enable automated, high-throughput cell engineering workflows. We demonstrate that using microfluidic devices with well-defined microchannel geometries and accurate flow control, uniform picolitre volume droplets (picodroplets) can be generated and used as miniaturized “test tubes” for high-throughput bioassays. We will showcase how we used picodroplet microfluidic technology to create novel, integrated and automated workflows for single cell genome editing, cell therapy, synthetic biology, and other research areas.
Presenter: Richard Hammond MA MEng, Chief Technical Officer, Sphere Fluidics
Presenter Biography: Richard is responsible for R&D at Sphere Fluidics, managing the development of their science and technology. Richard has over 20 years of experience in developing cutting-edge commercial products for healthcare and life sciences. Richard has held numerous senior positions responsible for product and technology development. At Alere Inc (now part of Abbott) he led several major cross-company R&D programs for in-vitro diagnostic devices including the development of the Alere i platform, the world’s first CLIA-waived point-of-care infectious disease diagnostic device using isothermal DNA amplification techniques. At Cambridge Consultants Ltd. Richard started their bioinnovation group, providing technical design and consultancy services at the intersection of biology and engineering. Over six years this group grew from one person to a team delivering substantial projects in areas such as automated cell transfection, CAR-T cell therapy manufacture, and digital data storage in DNA. Most recently Richard was VP of Technology at DNA Electronics, leading the R&D team in developing a novel fully-automated sample-to-answer in-vitro diagnostic platform using DNA sequencing. Richard holds MA and MEng degrees in engineering from the King’s College University of Cambridge.
Presentation Time: Thursday 25 May 11:00-11:15
Exhibition Booth: Don’t forget to swing by Booth 325 to learn more from our knowledgeable team and engage in insightful discussions about how our microfluidic picodroplet technology can help you find that valuable cell with ease and speed.
While you’re visiting don’t forget to stamp your Passport to Prizes card to be able to enter the prize draw. You can also enter our own prize draw to win Apple Air Pods or an Apple Watch. Speak to our team for more information about how to enter.
We can’t wait to connect with you, see you there!